Warning: The NCBI web site requires JavaScript to function. more...
Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-making framework to growth hormone for Turner syndrome patients.
Goetghebeur MM, Wagner M, Khoury H, Rindress D, Grégoire JP, Deal C.
Cost Eff Resour Alloc. 2010 Apr 8;8:4.
Related citations
Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.
Tony M, Wagner M, Khoury H, Rindress D, Papastavros T, Oh P, Goetghebeur MM.
BMC Health Serv Res. 2011 Nov 30;11:329.
Bridging Health Technology Assessment (HTA) and Efficient Health Care Decision Making with Multicriteria Decision Analysis (MCDA): Applying the EVIDEM Framework to Medicines Appraisal.
Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D.
Med Decis Making. 2011 Oct 10. [Epub ahead of print]
Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.
BMC Health Serv Res. 2008 Dec 22;8:270. Review.
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.
The use of economic evaluations in NHS decision-making: a review and empirical investigation.
Williams I, McIver S, Moore D, Bryan S.
Health Technol Assess. 2008 Apr;12(7):iii, ix-x, 1-175.
A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.
Claxton K, Ginnelly L, Sculpher M, Philips Z, Palmer S.
Health Technol Assess. 2004 Jul;8(31):1-103, iii.
Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE, Kleijnen J.
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29.
Generalisability in economic evaluation studies in healthcare: a review and case studies.
Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.
Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
[Procedures and methods of benefit assessments for medicines in Germany].
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. Epub 2008 Nov 25. German.
Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.
Robinson M, Palmer S, Sculpher M, Philips Z, Ginnelly L, Bowens A, Golder S, Alfakih K, Bakhai A, Packham C, Cooper N, Abrams K, Eastwood A, Pearman A, Flather M, Gray D, Hall A.
Health Technol Assess. 2005 Jul;9(27):iii-iv, ix-xi, 1-158. Review.
Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J.
Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. Review.
An assessment of the impact of the NHS Health Technology Assessment Programme.
Hanney S, Buxton M, Green C, Coulson D, Raftery J.
Health Technol Assess. 2007 Dec;11(53):iii-iv, ix-xi, 1-180. Review.
Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.
King M, Nazareth I, Lampe F, Bower P, Chandler M, Morou M, Sibbald B, Lai R.
Health Technol Assess. 2005 Sep;9(35):1-186, iii-iv. Review.
A review and critique of modelling in prioritising and designing screening programmes.
Karnon J, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J, Madan J.
Health Technol Assess. 2007 Dec;11(52):iii-iv, ix-xi, 1-145. Review.
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.
Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.
A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.
Connock M, Juarez-Garcia A, Frew E, Mans A, Dretzke J, Fry-Smith A, Moore D.
Health Technol Assess. 2006 Jun;10(20):iii-iv, ix-113. Review.
Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden.
Schwarzer R, Siebert U.
Int J Technol Assess Health Care. 2009 Jul;25(3):305-14. Review.
Rational decision-making in mental health: the role of systematic reviews.
Gilbody SM, Petticrew M.
J Ment Health Policy Econ. 1999 Sep 1;2(3):99-106.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on